Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Bayer receives FDA clearance for new blood glucose monitoring system

Bayer receives FDA clearance for new blood glucose monitoring system

Two-thirds of adults support single-dose packaging to avoid accidental poisoning

Two-thirds of adults support single-dose packaging to avoid accidental poisoning

DDW to be held May 19-22 in San Diego

DDW to be held May 19-22 in San Diego

ASN participates in ABIM Foundation's Choosing Wisely campaign

ASN participates in ABIM Foundation's Choosing Wisely campaign

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

IDSA releases new rhinosinusitis guidelines

IDSA releases new rhinosinusitis guidelines

New method can predict whether Tylenol-poisoning patients need liver transplant

New method can predict whether Tylenol-poisoning patients need liver transplant

Common misconceptions about brain and severity of head injuries

Common misconceptions about brain and severity of head injuries

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

GSA's new resources address pain management, labeling changes for acetaminophen

GSA's new resources address pain management, labeling changes for acetaminophen

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

Powerful painkiller on its way to the market: Experts worry about addiction woes

Powerful painkiller on its way to the market: Experts worry about addiction woes

Viewpoints: Wyden and Ryan on their Medicare plan; Frist on the need for international health aid

Viewpoints: Wyden and Ryan on their Medicare plan; Frist on the need for international health aid

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Acetaminophen over-use can lead to serious liver damage

Acetaminophen over-use can lead to serious liver damage

Study reveals principal mechanism of action for paracetamol

Study reveals principal mechanism of action for paracetamol

Covidien fourth quarter net sales increase 15% to $3.08 billion

Covidien fourth quarter net sales increase 15% to $3.08 billion

Low-grade inflammatory processes drive development of osteoarthritis

Low-grade inflammatory processes drive development of osteoarthritis

APF launches new online educational module on safe use of CAM

APF launches new online educational module on safe use of CAM

Ferring reports on FDA approval of labeling supplement for EUFLEXXA to treat knee osteoarthritis

Ferring reports on FDA approval of labeling supplement for EUFLEXXA to treat knee osteoarthritis